Abstract
A strain, designated as FM-6, was isolated from fish. Based on the results of phenotypic, physiological characteristics, genotypic and phylogenetic analysis, strain FM-6 was finally identified as Paenibacillus sp. When albendazole was provided as the sole carbon source, strain FM-6 could grow and transform albendazole. About 82.7 % albendazole (50 mg/L) was transformed by strain FM-6 after 5 days incubation at 30 °C, 160 rpm. With HPLC–MS method, the transforming product of albendazole was researched. Based on the molecular weight and the retention time, product was identified as albendazole sulfoxide and the transforming pathway of albendazole by strain FM-6 was proposed finally. The optimum temperature and pH for the bacterium growth and albendazole transformation by strain FM-6 were both 30 °C and 7.0. Moreover, the optimum concentration of albendazole for the bacterium growth was 50 mg/L. Coupled with practical production, 50 mg/L was the optimum concentration of albendazole transformation for strain FM-6. This study highlights an important potential use of strain FM-6 for producing albendazole sulfoxide.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ash C, Priest FG, Collins MD (1993) Molecular identification of rRNA group 3 bacilli (Ash, Farrow, Wallbanks and Collins) using a PCR probe test. Proposal for the creation of a new genus Paenibacillus. Anton Van Leeuwenhoek 64:253–260
Bogan JA, Marriner SE (1984) Pharmacodynamic and toxicological aspects of albendazole in man and animals. In: Fock M (ed) Albendazole in helminthiasis. Royal Society of Medicine International Congress and Symposium, Series 61, Royal Society of Medicine, London, pp 13–21
Chandel AK, Venkateswar RL, Lakshmi NM, Singh OV (2008) The realm of penicillin G acylase in beta-lactam antibiotics. Enzyme Microb Tech 42:199–207
Franz JS, John DR, James FP (2006) Paenibacillus sp. strain JDR-2 and XynA1: a novel system for methylglucuronoxylan utilization. Appl Environ Microbiol 72:1496–1506
Holt JG, Krieg NR, Sneath PHA, Staley JT, Williams ST (1994) Bergey’s manual of determinative bacteriology, 9th edn. Williams & Wilkins, Baltimore, pp 626–640
Hussar DA (1997) New drugs of 1996. J Am Pharm Assoc NS37:192–228
Jin L, Guo YM, Chen XC, Bao JJ, Song K (2013) Isolation and characterization of an albendazole-degrading strain ZS-1 and its degrading characteristics. Chin J Agr Biotechnol 21:1103–1109
Lal S, Tabacchioni S (2009) Ecology and biotechnological potential of Paenibacillus polymyxa: a minireview. Indian J Microbiol 49:2–10
Lane DJ (1991) 16S/23S rRNA sequencing. In: Stackebrandt E, Goodfellow M (eds) Nucleic acid techniques in bacterial systematics. Wiley, Chichester, pp 371–375
Marriner SE, Morris DL, Dickson B, Bogan JA (1986) Pharmacokinetics of albendazole in man. Eur J Clin Pharmacol 30:705–708
McSpadden GBB (2004) Ecology of Bacillus and Paenibacillus sp. in agricultural systems. Phytopathology 94:1252–1258
Montes MJ, Mercade E, Bozal N, Guinea J (2004) Paenibacillus antarcticus sp. nov., a novel psychrotolerant organism from the Antarctic environment. Int J Syst Evol Microbiol 54:1521–1526
Ouyang J, Pei Z, Lutwick L, Dalal S, Yang L, Cassai N, Sandhu K, Hanna B, Wieczorek RL, Bluth M, Pincus MR (2008) Case report: Paenibacillus thiaminolyticus: a new cause of human infection, inducing bacteremia in a patient on hemodialysis. Ann Clin Lab Sci 38:393–400
Prasad GS, Girisham S, Reddy SM, Srisailam K (2008) Biotransformation of albendazole by fungi. World J Microbiol Biotechnol 24:1565–1571
Prasad GS, Girisham S, Reddy SM (2011) Potential of thermophilic fungus Rhizomucor pusillus NRRL 28626 in biotransformation of antihelmintic drug albendazole. Appl Biochem Biotechnol 165:1120–1128
Quinn GA, Maloy AP, McClean S, Carney B, Slater JW (2012) Lipopeptide biosurfactants from Paenibacillus polymyxa inhibit single and mixed species biofilms. Biofouling 28:1151–1166
Shaheen M, Li J, Ross AC, Vederas JC, Jensen SE (2011) Paenibacillus polymyxa PKB1 produces variants of polymyxin B-type antibiotics. Chem Biol 18:1640–1648
Sun CY, Zhao YP, Guo JH (2012) Determination of related substances in albendazole by HPLC. Chin J Mod Appl Pharm 29:264–267
Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 24:1596–1599
Venisetty RK, Ciddi V (2003) Application of microbial biotransformation for the new drug discovery using natural drugs as substrates. Curr Pharm Biotechnol 4:123–140
Yegorenkova IV, Tregubova KV, Ignatov VV (2013) Paenibacillus polymyxa rhizobacteria and their synthesized exoglycans in interaction with wheat roots: colonization and root hair deformation. Curr Microbiol 66:481–486
Zhang XJ, Chen XC, Guo YM, Mei GM, Yang HC, Zheng B (2011a) Determination of albendazole sulfoxide, albendazole sulfone and albendazole aminosulfone in freshwater fish products. Chin Fish Qual Stan 1:60–63
Zhang XJ, Xu HX, Zhang H, Guo YM, Dai ZY, Chen XC (2011b) Simultaneous determination of albendazole and its metabolites in fish muscle tissue by stable isotope dilution ultra-performance liquid chromatography tandem mass spectrometry. Anal Bioanal Chem 401:727–734
Acknowledgments
This work was supported by grants from Science and Technology Plan Projects of Zhejiang Province,China (2012F20026, 2012C13005) and the Open Project Program of Marine Fishery Institute of Zhejiang Province (2009–2006).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jin, L., Zhang, X., Sun, X. et al. Isolation and identification of Paenibacillus sp. FM-6, involved in the biotransformation of albendazole. World J Microbiol Biotechnol 30, 2747–2754 (2014). https://doi.org/10.1007/s11274-014-1698-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11274-014-1698-9